USPTO serial 79372000
N NEURODE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 11, 2025
- Examiner
- CLYBURN, CARLA DIONNE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with N NEURODE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janice Housey
Janice Housey LITMUS LAW PLLC4 WEEMS LANE #240Turramurra Box CentreWINCHESTER, VA 22601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Measuring devices for diagnosing and treating neurological conditions and monitoring cognitive performance used for medical purposes; measuring devices having digital displays for diagnosing and treating neurological conditions and monitoring cognitive performance for medical use; sensing devices for medical use in monitoring the vital signs of patients; apparatus for electrical muscle stimulation used for medical purposes; apparatus for the electrical stimulation of groups of muscles used for medical purposes; contact apparatus for deriving electrical signals from human bodies used for medical purposes; electric apparatus for therapeutic application to the body to improve cognitive performance for people with neurological conditions; electrical apparatus for analysis of cognitive behaviour used for medical purposes; electrical apparatus for medical diagnosis of neurological conditions; electrical apparatus for medical purposes for applying therapeutic stimulation to the body to improve cognitive performance for people with neurological conditions; electrical apparatus for medical treatment of neurological conditions; electrical appliances used for diagnosing and treating neurological conditions and monitoring cognitive performance for curative purposes; electrical appliances, namely, minimally invasive neurovascular devices for the diagnosis and treatment of neurological conditions and for monitoring cognitive performance for medical purposes; electrical machines, namely, headsets for use in treating neurological conditions of the human body; electrical nerve stimulators used for diagnosing and treating neurological conditions and monitoring cognitive performance; electrically operated medical apparatus used for diagnosing and treating neurological conditions and monitoring cognitive performance; transcutaneous electrical nerve stimulation electrodes used for diagnosing and treating neurological conditions and monitoring cognitive performance; transcutaneous electrical nerve stimulation instruments used for diagnosing and treating neurological conditions and monitoring cognitive performance; transcutaneous electrical nerve stimulators; transcutaneous electrical muscle stimulators used for diagnosing and treating neurological conditions and monitoring cognitive performance; analytical instruments, namely, headsets used for diagnosing and treating neurological conditions and monitoring cognitive performance for medical use; detecting instruments for cognitive performance for medical use; diagnostic instruments for neurological conditions for medical use; electro-medical diagnostic instruments used for diagnosing and treating neurological conditions and monitoring cognitive performance; instruments for diagnosis of neurological conditions for medical use | ACTIVE | — |
| 042 | Software as a service (SaaS) featuring software for diagnosing and treating neurological conditions and monitoring cognitive performance; software as a service (SaaS) featuring software for the collection, measurement, monitoring, analysing, displaying, reporting, sharing, management, and storage of neurological data; online provision of temporary use of non-downloadable web-based applications for diagnosing and treating neurological conditions and monitoring cognitive performance ; online provision of temporary use of non-downloadable web-based applications for the collection, measurement, monitoring, analysing, displaying, reporting, sharing, management, and storage of neurological data; online provision of temporary use of non-downloadable web-based software for diagnosing and treating neurological conditions and monitoring cognitive performance ; online provision of temporary use of non-downloadable web-based software for the collection, measurement, monitoring, analysing, displaying, reporting, sharing, management, and storage of neurological data; design and development of computer software; consultancy in the design and development of computer software; computer security services in the nature of design and development of secure computer hardware, software and systems; development of computer software application solutions; providing information, including online, about design and development of computer hardware and software; research and development of new products for others; scientific research into the development of new products; technical research into the development of new products; advisory services relating to product testing; biotechnology testing for others in the field of neurology; platform as a service (PaaS) featuring computer software platforms for diagnosing and treating neurological conditions and monitoring cognitive performance; platform as a service (PaaS) featuring computer software platforms for the collection, measurement, monitoring, analysing, displaying, reporting, sharing, management, and storage of neurological data; development of computer platforms; creating and maintaining weblogs for others | ACTIVE | — |
| 044 | Medical services; medical diagnostic services in the nature of testing and analysis of cognitive performance for diagnosing and treating neurological conditions; medical counselling; medical clinic services; medical care services; medical service for the treatment of neurological conditions; medical neurology treatment services; providing medical information to patients and medical professionals in the form of reports in the field of neurology; providing medical information including online; provision of medical information; provision of medical treatment of neurological conditions; remote monitoring of medical data for medical diagnosis and treatment of neurological conditions; medical reporting services in the nature of preparation of medical reports; behavioural analysis for medical purposes; provision of information relating to behavioural modification for therapy or medical purposes; medical consultancy and advisory services; preparation of psychological profiles for medical purposes via a website that is designed to provide custom tailored outputs about recommended resources and treatments associated with neurological symptoms and concerns; lifestyle counselling in the form of psychological therapy for patients with neurological conditions; psychological testing for medical purposes; psychological counselling; ADHD screening services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Neurode Pty Ltd
- Other trademarks owned by Neurode Pty Ltd
- Other trademarks owned by Neurode Pty Ltd
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named N NEURODE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 25, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 12, 2025 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 27, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 27, 2025 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 25, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 11, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 28, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 11, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 11, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 3, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 3, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 24, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 24, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 18, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 2, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 2, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 2, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 2, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 2, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 21, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 21, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 25, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 25, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 25, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 14, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 14, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 23, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 22, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 20, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 16, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 15, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |